Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic M Pondal, C Marras, J Miyasaki, E Moro, MJ Armstrong, AP Strafella, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (2), 130-135, 2013 | 121 | 2013 |
Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial BJ Wainger, EA Macklin, S Vucic, CE McIlduff, S Paganoni, NJ Maragakis, ... JAMA neurology 78 (2), 186-196, 2021 | 109 | 2021 |
Pallidal deep brain stimulation modulates cortical excitability and plasticity Z Ni, SJ Kim, N Phielipp, S Ghosh, K Udupa, CA Gunraj, U Saha, ... Annals of neurology 83 (2), 352-362, 2018 | 62 | 2018 |
N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis B Elahi, N Phielipp, R Chen Canadian journal of neurological sciences 39 (4), 465-472, 2012 | 59 | 2012 |
Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor AJ Espay, MJ Edwards, GD Oggioni, N Phielipp, B Cox, ... Parkinsonism & related disorders 20 (6), 647-650, 2014 | 53 | 2014 |
Frameless stereotactic robot-assisted subthalamic nucleus deep brain stimulation: case report S Vadera, A Chan, T Lo, A Gill, A Morenkova, NM Phielipp, ... World neurosurgery 97, 762. e11-762. e14, 2017 | 51 | 2017 |
What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease? TA Mestre, I Beaulieu-Boire, CC Aquino, N Phielipp, YY Poon, JP Lui, ... Parkinsonism & Related Disorders 21 (11), 1349-1354, 2015 | 31 | 2015 |
Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson’s disease M Paff, AS Wang, N Phielipp, S Vadera, A Morenkova, N Hermanowicz, ... Journal of robotic surgery 14, 559-565, 2020 | 21 | 2020 |
Movement disorders: Genetics and models MS LeDoux Elsevier, 2014 | 21 | 2014 |
Safety of repetitive transcranial magnetic stimulation in patients with implanted cortical electrodes. An ex-vivo study and report of a case NM Phielipp, U Saha, T Sankar, A Yugeta, R Chen Clinical Neurophysiology 128 (6), 1109-1115, 2017 | 17 | 2017 |
A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia MB Coulthart, MD Geschwind, S Qureshi, N Phielipp, A Demarsh, ... Brain 139 (10), 2609-2616, 2016 | 16 | 2016 |
Superficial siderosis and dural ectasia in a patient with Marfan syndrome M Bower, M Farag, N Phielipp Clinical Neuroradiology 28, 605-607, 2018 | 4 | 2018 |
Neurophysiologic assessment of movement disorders in humans NM Phielipp, R Chen Movement Disorders, 171-186, 2015 | 3 | 2015 |
Intracranial hypotension with mild Parkinsonism and bulbar dysfunction KT Cochran, AN Hasso, NM Phielipp Neurology: Clinical Practice 11 (1), e22-e24, 2021 | 2 | 2021 |
Quantified striatal dopaminergic denervation as predictor for motor outcomes in parkinson's disease I Trinh, A Muralidhar, J Yang, N Phielipp Movement Disorders Clinical Practice 10 (6), 896-902, 2023 | 1 | 2023 |
Safety and preliminary clinical findings of neurosurgical AAV2-GDNF delivery for Parkinson's disease AD Van Laar, CW Christine, A Merola, NM Phielipp, JB Elder, PS Larson, ... MOLECULAR THERAPY 30 (4), 374-375, 2022 | 1 | 2022 |
Evidence-based advances in the treatment of motor features of Parkinson's disease A Al Dakheel, NM Phielipp, J Miyasaki Neurodegenerative Disease Management 3 (4), 331-341, 2013 | 1 | 2013 |
AAV2-GDNF Gene Delivery in Mild-and Moderate-Stages of Parkinson’s Disease: Preliminary Brain Imaging and Clinical Outcomes A Van Laar, C Christine, N Phielipp, A Merola, JB Elder, P Larson, ... Parkinsonism & Related Disorders 122, 2024 | | 2024 |
Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease (N2. 001) A Van Laar, C Christine, A Merola, N Phielipp, B Elder, P Larson, ... Neurology 102 (17_supplement_1), 6786, 2024 | | 2024 |
Safety and clinical findings 12-months following bilateral putaminal convection enhanced delivery of AAV2-GDNF in early and moderate stages of Parkinson's Disease AD Van Laar, CW Christine, A Merlola, NM Phielipp, JB Elder, PS Larson, ... HUMAN GENE THERAPY 33 (23-24), A70-A71, 2022 | | 2022 |